Schwar Capital Research

Schwar Capital Research

TruFin Final Results: Every Line Beat, the Operating Leverage Is Real (TRU.L)

Audited numbers confirm it. This business is scaling while returning cash to shareholders.

Schwar Capital Research's avatar
Schwar Capital Research
Mar 20, 2026
∙ Paid

To read our full disclaimer, click here.

TruFin published its audited final results for 2025 on Wednesday morning.

The headline: every key financial metric beat even the already-upgraded preliminary numbers from January. Revenue grew 20% to £65.9 million, adjusted EBITDA surged 66% to £12.6 million, and adjusted PBT came in at £8.4 million - up 848% year-on-year. That’s not a typo.

The stock is trading around £1.20, roughly flat since our last update. The market cap sits at approximately £117 million.

I think the market is still missing the story.

The Numbers vs. Our January Estimates

The January 15th trading update gave us preliminary figures. Here’s how the audited results compare:

  • Group revenue: ~£63m estimated → £65.9m actual (beat)

  • Adjusted EBITDA: >£11.8m estimated → £12.6m actual (beat)

  • Adjusted PBT: >£7.4m estimated → £8.4m actual (beat by 13.5%)

  • Year-end cash: >£12m estimated → £12.4m actual (in line)

Every number came in ahead. Adjusted EBIT - the metric that strips out capitalised development costs and shows true operating profitability - increased 699% year-on-year. That’s the operating leverage we’ve been waiting for.

Reported profit before tax was £7.6 million, up from essentially zero (£15,000) in 2024. After a £3.9 million tax credit - largely from recognising deferred tax assets against the group’s £79 million of carried-forward tax losses - profit for the year was £11.5 million. Basic EPS came in at 11.3p, up from 4.6p.

At £1.20, the stock trades on approximately 10x adjusted earnings. For a group growing revenue 20% and EBITDA 66%. With a debt-free balance sheet.

In the rest of this post, I discuss:

  • How each subsidiary performed against expectations

  • The balance sheet transformation

  • The underappreciated £79 million tax shield

  • Why Satago might be inflecting

  • Updated base and bull case valuations

  • What I’m watching from here

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Schwar Capital · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture